DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,125,000 | -83.7% | 100,000 | -83.3% | 0.00% | -87.5% |
Q1 2023 | $6,912,000 | +49.1% | 600,000 | +50.0% | 0.02% | +45.5% |
Q4 2022 | $4,636,000 | -18.9% | 400,000 | -11.1% | 0.01% | -21.4% |
Q3 2022 | $5,715,000 | +45.9% | 450,000 | -21.1% | 0.01% | +55.6% |
Q2 2022 | $3,916,000 | -45.8% | 570,000 | -24.0% | 0.01% | -35.7% |
Q1 2022 | $7,230,000 | +508.1% | 750,000 | +650.0% | 0.01% | +600.0% |
Q4 2021 | $1,189,000 | +46.4% | 100,000 | +100.0% | 0.00% | 0.0% |
Q3 2021 | $812,000 | -61.4% | 50,000 | -50.0% | 0.00% | -50.0% |
Q2 2021 | $2,104,000 | – | 100,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |